APA (7th ed.) Citation

SO, R., HK, J., MS, J., H, M., S, D., A, P., . . . YF, M. (2025). Harnessing IDO inhibitors to optimize cancer immunotherapy. Naunyn-Schmiedeberg's archives of pharmacology, 398(12), 16797. https://doi.org/10.1007/s00210-025-04445-9

Chicago Style (17th ed.) Citation

SO, Rab, et al. "Harnessing IDO Inhibitors to Optimize Cancer Immunotherapy." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 12 (2025): 16797. https://doi.org/10.1007/s00210-025-04445-9.

MLA (9th ed.) Citation

SO, Rab, et al. "Harnessing IDO Inhibitors to Optimize Cancer Immunotherapy." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 12, 2025, p. 16797, https://doi.org/10.1007/s00210-025-04445-9.